NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,327,671 | -26.2% | 225,165 | -2.4% | 0.00% | 0.0% |
Q2 2023 | $5,866,122 | +70220.3% | 230,768 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $8,342 | +25.3% | 230,768 | +37.3% | 0.00% | 0.0% |
Q4 2022 | $6,657 | -99.9% | 168,121 | +26.4% | 0.00% | 0.0% |
Q3 2022 | $6,200,000 | +3.2% | 133,049 | -3.0% | 0.00% | +50.0% |
Q2 2022 | $6,010,000 | -36.8% | 137,135 | -3.3% | 0.00% | -33.3% |
Q1 2022 | $9,509,000 | +12.1% | 141,831 | +35.8% | 0.00% | 0.0% |
Q4 2021 | $8,486,000 | -85.1% | 104,477 | -78.7% | 0.00% | -83.3% |
Q3 2021 | $57,090,000 | -36.2% | 490,549 | -9.1% | 0.02% | -33.3% |
Q2 2021 | $89,518,000 | +25.6% | 539,943 | +5.7% | 0.03% | +17.4% |
Q1 2021 | $71,271,000 | -15.5% | 510,896 | +4.8% | 0.02% | -20.7% |
Q4 2020 | $84,361,000 | +50.4% | 487,357 | +21.1% | 0.03% | +31.8% |
Q3 2020 | $56,083,000 | +24.4% | 402,605 | +6.7% | 0.02% | +22.2% |
Q2 2020 | $45,089,000 | +98.9% | 377,407 | +66.4% | 0.02% | +63.6% |
Q1 2020 | $22,671,000 | -30.4% | 226,754 | -18.2% | 0.01% | -8.3% |
Q4 2019 | $32,583,000 | +81.2% | 277,206 | +32.5% | 0.01% | +71.4% |
Q3 2019 | $17,980,000 | -33.0% | 209,137 | -49.4% | 0.01% | -36.4% |
Q2 2019 | $26,818,000 | +2696.5% | 413,667 | +2878.6% | 0.01% | +83.3% |
Q4 2017 | $959,000 | -90.9% | 13,888 | -88.0% | 0.01% | -91.3% |
Q3 2017 | $10,520,000 | +698.8% | 115,752 | +554.0% | 0.07% | +762.5% |
Q2 2017 | $1,317,000 | -16.6% | 17,700 | +5.1% | 0.01% | -11.1% |
Q1 2017 | $1,579,000 | +26.6% | 16,847 | -1.8% | 0.01% | +50.0% |
Q4 2016 | $1,247,000 | +2.9% | 17,159 | +47.7% | 0.01% | -14.3% |
Q3 2016 | $1,212,000 | -3.0% | 11,615 | -31.4% | 0.01% | -12.5% |
Q2 2016 | $1,250,000 | – | 16,943 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |